The grants will be distributed over five years and both are part of the NIH’s Helping to End Addiction Long-term Initiative.
The first study, which has been awarded $25 million in funding, will take place at more than 40 primary care clinics across the U.S. and will analyze how telemedicine helps solve treatment barriers such as long travel times to clinics in rural areas.
The second study will use the remaining $3.3 million from NIH to explore the use of text messages as support for opioid addiction treatment. Researchers will analyze whether using text messages to deliver cognitive behavioral therapy will help patients stick to their opioid treatment medication regimens.
More articles on telehealth:
Will Amazon’s telemedicine program spread beyond employees?
Oklahoma State University leverages telemedicine to treat opioid addiction
Texas Health Resources launches telehealth exams for sexual assault victims
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
